Dysferlinopathy is characterized by the loss (or significant reduction to <10% normal levels) of the dysferlin protein (encoded by the DYSF gene) in the skeletal muscle of affected patients and has an autosomal recessive mode of inheritance [3]. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.